[Prevalence of multiple sclerosis in the Region of Murcia]

E Carreon-Guarnizo1,2, E Andreu-Reinon3, M Cerdan-Sanchez3,2

  • 1Hospital Universitario Virgen de la Arrixaca., El Palmar, Espana.

Revista De Neurologia
|April 27, 2016
PubMed
Abstract

Insights

Multiple sclerosis (MS) prevalence in Murcia is similar to other Spanish regions, confirming an increasing trend. The study also examined clinical features and Epstein-Barr virus (EBV) status in MS patients.

Area of Science:

  • Neurology
  • Epidemiology
  • Immunology

Background:

  • Multiple sclerosis (MS) is an immune-mediated demyelinating CNS disease.
  • Research indicates rising MS prevalence and a link with Epstein-Barr virus (EBV).

Purpose of the Study:

  • To analyze MS prevalence and clinical characteristics in the Region of Murcia.
  • To assess EBV serological status in MS patients.

Main Methods:

  • Retrospective epidemiological study in the central-west healthcare area of Murcia.
  • Analysis of clinical and serological data from 257,865 inhabitants.

Main Results:

  • MS prevalence: 88 cases/100,000 population; with isolated demyelinating syndrome: 98.4 cases/100,000.
  • Typical onset: 31.4 years, 67.8% female, relapsing-remitting course (81.9%), sensory system most affected (45.1%).
  • EBV seroprevalence was 99.3%; reactivation linked to MS activity in 45.4% of cases.

Conclusions:

  • MS prevalence in Murcia aligns with other Spanish regions.
  • The study confirms a growing trend in MS prevalence over recent decades.